|
|
Michael Castagna
Vice President
Global Commercial Lead, Biosimilars Business
Amgen
|
| |
|
|
|
|
Gina Kampfer
Global Biosimilars Lead, Payer Insights & Access
Pfizer Inc.
|
| |
|
|
|
Raj Kannan
Vice President
Global Commercial Head
Biosimilars Unit
EMD Serono
|
| |
|
|
|
April Kunze
Director, Formulary Development and Pipeline
Prime Therapeutics
|
| |
|
|
|
Bruce A. Leicher
Senior Vice President and General Counsel
Momenta Pharmaceuticals, Inc.
|
| |
|
|
|
|
|
Douglas M. Long
Vice President, Industry Relations
IMS Health, Inc.
*Mr. Long is presenting remotely. He is still be able to take questions from the audience.
|
| |
|
|
|
Serge Messerlian
Vice President, Commercial Head - Biosimilars
Baxter Healthcare Corp.
|
| |
|
|
|
|
|
|
|
Peter J. Pitts
President
Center for Medicine in the Public Interest
Former Associate Commissioner, US Food and Drug Administration
|
| |
|
|
|
|
|
Thomas Sullivan
President, Rockpointe Corporation
Editor, Policy and Medicine
Co-founder, Association of Clinical Researchers and Educators
|
| |
|
|
|
Alex Waldron
VP Global Commercial Operations
Epirus Biopharmaceuticals
|
| |
|
